Safety and advantages of VATS biopsy in diagnosis of interstitial lung disease

Luca Bertolaccini (Negrar Verona, Italy), Luca Bertolaccini, Simona Paiano, Carlo Pomari, Luca Rosario Assante, Andrea Viti, Alberto Terzi

Source: International Congress 2015 – Challenges in surgery for non-malignant disorders: pleural mediastinal and tracheal problems, congenital disorders
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Luca Bertolaccini (Negrar Verona, Italy), Luca Bertolaccini, Simona Paiano, Carlo Pomari, Luca Rosario Assante, Andrea Viti, Alberto Terzi. Safety and advantages of VATS biopsy in diagnosis of interstitial lung disease. Eur Respir J 2015; 46: Suppl. 59, 1518

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
A multicentre evaluation of inter-multidisciplinary team agreement for diagnosis in diffuse lung disease
Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases
Year: 2016

Which are the interstitial lung diseases where core needle biopsy has diagnostic utility?
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015

What (and how) do we attain by performing surgical lung biopsy for interstitial lung disease?
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015


Relevance of the expert ILD clinical-radiological evaluation of referred cases to the MDT
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016


The efficacy of cyclosporine A in patients with clinicoradiologically diagnosed idiopathic nonspecific interstitial pneumonia
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014


The role of detection of myositis specific and associated antibodies in Japanese patient with interstitial lung disease
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014


Rituximab in severe, treatment-refractory interstitial lung disease
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013

"Cyclophosphamide for the treatment of inflammation driven fibrotic interstitial lung disease"
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014

Clinical course and outcome of vasculitis related interstitial lung disease
Source: International Congress 2014 – ILDs 2
Year: 2014

A multicentre evaluation of inter-multidisciplinary team agreement for predicted disease behaviour and management strategy in diffuse lung disease
Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases
Year: 2016

The clinical value of surgical lung biopsy in 166 patients with suspected interstitial lung disease
Source: International Congress 2015 – New insights into IIPs
Year: 2015

Complications and mortality of tranbronchial lung cryobiopsy and surgical lung biopsy in interstitial lung diseases
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015


Idiopathic non-specific interstitial pneumonia (iNSIP): do the patients develop connective tissue disease (CTD) during follow-up?
Source: International Congress 2016 – Connective tissue disorders
Year: 2016

Diagnostic utility of surgical lung biopsies in elderly patients with interstitial lung diseases
Source: International Congress 2015 – New insights into IIPs
Year: 2015

Study of factors affecting mortality in ILD cases over 2 years
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016


Immunosuppressive treatment is not a predictor of mortality after surgical lung biopsy for interstitial lung disease
Source: International Congress 2016 – Sarcoidosis
Year: 2016

Antisynthetase syndrome (AS) in patients with diffuse interstitial lung disease (ILD)
Source: International Congress 2015 – Connective tissue disorders
Year: 2015

Clinical efficacy of pirfenidone in patients with severe fibrosing interstitial pneumonia
Source: International Congress 2015 – Treatment of IPF
Year: 2015


OSA with intertitial lung diseases
Source: International Congress 2016 – Effect of sleep apnoea on life-span and comorbidities
Year: 2016

Interstitial lung disease in the connective tisssue disease
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014